Get notified when INUV files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- The Issuance of Our Common Stock Upon Exercise of the Common Warrants May Cause Dilution and the Sale of the Shares of Common Stock Acquired By the Selling Stockholders, or the Perception That Such Sales May Occur, Could Cause the Price of Our Common Stock to Decrease. (new) — The prospectus explicitly warns that warrant exercise and selling stockholder sales could dilute existing shareholders and depress the stock price.
Inuvo files 424B3 for resale of up to 6.09M shares by selling stockholders; company gets no proceeds
Filed August 7, 2026 · ~2 min read
Key Changes
-
high
The offering is entirely a secondary resale of up to 6,086,069 shares underlying warrants by two selling stockholders; Inuvo sells no shares and receives no proceeds from those sales.
The Offering verify on EDGAR → -
high
If all common warrants are exercised for cash, Inuvo could receive up to approximately $7.8 million in gross proceeds, but exercise is at warrant holders' discretion.
Use of Proceeds verify on EDGAR → -
high
Inuvo recently raised $10 million in secured notes, using proceeds to retire $2.8 million of convertible debt and terminate its receivables credit facility; no convertible debt remains.
Prospectus Summary verify on EDGAR →
2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (MU 10-K) is open in full — no account needed.
Partner
Trade INUV commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Sep 1, 2026 · How we verify